Sarissa Capital seeks to oust Ariad Pharma CEO-Reuters
Sarissa Capital Management LP kicked off a proxy battle with Ariad Pharmaceuticals Inc on Friday, demanding the retirement of Harvey Berger, the drugmaker's chief executive and principal founder, Reuters reported.



